ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

DOD Breast Cancer Program Releases Research Solicitation

October 1, 1993

ACCC To Take In State Chapters, Forms Trials Group

April 6, 1990

DeVita Says He Did Not Agree To Include “Chop-Like” Elements In CCOP RFA But That He Would Consider It

March 19, 1982

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

PDQ Now Offers CME Credit to Physician Users

July 3, 1987